Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Dow
Moodys
Medtronic
Merck
Express Scripts
McKinsey

Last Updated: January 19, 2022

DrugPatentWatch Database Preview

Investigational Drug Information for Eleclazine


Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug Eleclazine?

Eleclazine is an investigational drug.

There have been 6 clinical trials for Eleclazine. The most recent clinical trial was a Phase 2 trial, which was initiated on December 17th 2014.

The most common disease conditions in clinical trials are Long QT Syndrome, Syndrome, and Hypertrophy. The leading clinical trial sponsors are Gilead Sciences and [disabled in preview].

There are twelve US patents protecting this investigational drug and one hundred and seventy-six international patents.

Recent Clinical Trials for Eleclazine
TitleSponsorPhase
Study to Evaluate the Effect of Eleclazine on QT, Safety, and Tolerability in Participants With Long QT2 SyndromeGilead SciencesPhase 1
Pharmacokinetics of Eleclazine in Adults With Normal and Impaired Renal FunctionGilead SciencesPhase 1
Pharmacokinetics of Eleclazine in Adults With Normal and Impaired Hepatic FunctionGilead SciencesPhase 1

See all Eleclazine clinical trials

Clinical Trial Summary for Eleclazine

Top disease conditions for Eleclazine
Top clinical trial sponsors for Eleclazine

See all Eleclazine clinical trials

US Patents for Eleclazine

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Eleclazine ⤷  Try it Free Fused heterocyclic compounds as CaM kinase inhibitors Gilead Sciences, Inc. (Foster City, CA) ⤷  Try it Free
Eleclazine ⤷  Try it Free Controlled release dosage form TRIASTEK, INC. (Nanjing, CN) ⤷  Try it Free
Eleclazine ⤷  Try it Free Oral drug dosage forms having desired drug release profiles and uses thereof Triastek, Inc. (Nanjing, CN) ⤷  Try it Free
Eleclazine ⤷  Try it Free Compartmented pharmaceutical dosage forms Triastek, Inc. (Nanjing, CN) ⤷  Try it Free
Eleclazine ⤷  Try it Free Fused heterocyclic compounds as ion channel modulators Gilead Sciences, Inc. (Foster City, CA) ⤷  Try it Free
Eleclazine ⤷  Try it Free Fused heterocyclic compounds as ion channel modulators Gilead Sciences, Inc. (Foster City, CA) ⤷  Try it Free
Eleclazine ⤷  Try it Free Methods of treating hypertrophic cardiomyopathy Gilead Sciences, Inc. (Foster City, CA) ⤷  Try it Free
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Eleclazine

Drugname Country Document Number Estimated Expiration Related US Patent
Eleclazine Argentina AR110252 2036-11-30 ⤷  Try it Free
Eleclazine European Patent Office EP3548495 2036-11-30 ⤷  Try it Free
Eleclazine Taiwan TW201831487 2036-11-30 ⤷  Try it Free
Eleclazine Taiwan TWI651325 2036-11-30 ⤷  Try it Free
Eleclazine World Intellectual Property Organization (WIPO) WO2018102384 2036-11-30 ⤷  Try it Free
Eleclazine Australia AU2017261372 2036-05-05 ⤷  Try it Free
Eleclazine Canada CA3023278 2036-05-05 ⤷  Try it Free
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Moodys
Medtronic
Merck
Express Scripts
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.